Endobronchial ultrasound allows physicians to easily view difficult-to-reach areas and provide more accurate diagnosis. Franciscan Health is proud to offer this advanced technology to patients suffering from lung disorders.
Although lung cancer accounts for only 13% of all newly-diagnosed cancers in the United States, it is the leading cause of cancer death in U.S. men and women. It is more deadly than colon, breast and prostate cancers combined. Any tools that we can use that help us detect lung disorders early, are powerful tools in the fight against cancer. Endobronchial ultrasound is one of those powerful tools.
Endobronchial ultrasound (EBUS) is a more accurate and less invasive way of assessing a patient's lymph nodes to diagnose lung cancer, infections or other diseases. While performing an endobronchial ultrasound, doctors have real-time imaging of the surface of the airways, blood vessels, lungs and lymph nodes. Endobronchial ultrasound offers an alternative to surgery and has proven to be a highly effective tool in the treatment of lung cancer.
An ultrasound guided endoscope or bronchoscope is passed through the mouth into the trachea. No incisions are needed. The airway and surrounding structures and lymph nodes can be viewed and sampled. The tests are highly accurate and often complement imaging diagnosis procedures. Performed together, the tests are more sensitive than either alone, and may become the next gold standard in lung cancer staging, the process of determining how much cancer is in the body and where it is located.
EBUS is typically performed as an outpatient procedure under moderate sedation and is often performed at the same time as electromagnetic navigational bronchoscopy.